comparemela.com

Latest Breaking News On - Cancer therapy radionuclide - Page 1 : comparemela.com

Patient-Reported Outcome Measure Developed for Radionuclide Therapy in Prostate Cancer

The Functional Assessment of Cancer Therapy-Radionuclide Therapy (FACT-RNT) patient-reported outcome (PRO) tool has been developed for measuring symptoms/toxicities among prostate cancer (PC) patients receiving RNT.

United statesLisa gudenkaufJournal of nuclear medicineMoffitt cancer centerHealthday newsFunctional assessmentCancer therapy radionuclideChronic illness therapy

Patient-Reported Outcome Measure Developed for Radionuclide Therapy in Prostate Cancer

Patient-Reported Outcome Measure Developed for Radionuclide Therapy in Prostate Cancer
renalandurologynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from renalandurologynews.com Daily Mail and Mail on Sunday newspapers.

United statesLisa gudenkaufJournal of nuclear medicineMoffitt cancer centerHealthday newsFunctional assessmentCancer therapy radionuclideChronic illness therapy

Patient-Reported Outcome Measure Developed for Radionuclide Therapy in Prostate Cancer

MONDAY, Feb. 6, 2023 (HealthDay News) The Functional Assessment of Cancer Therapy-Radionuclide Therapy (FACT-RNT) patient-reported outcome (PRO) tool has been developed for measuring symptoms/toxicities among prostate cancer (PC) patients receiving RNT, according to a report published online Jan. 12 in the Journal of Nuclear Medicine. Lisa Gudenkauf, Ph.D., from the Moffitt Cancer Center in

United statesLisa gudenkaufJournal of nuclear medicineMoffitt cancer centerHealthday newsFunctional assessmentCancer therapy radionuclideChronic illness therapy

FACT-RNT: A PRO Tool for Prostate Cancer Patients on Radionuclide Therapy

Researchers have developed FACT-RNT, a patient-reported outcome tool for prostate cancer patients receiving radionuclide therapy.

Journal of nuclear medicineHealthday newsCancer therapy radionuclide

Patient-Reported Outcome Measure Developed for Radionuclide Therapy in Prostate Cancer

The FACT-RNT PRO tool has been developed for measuring symptoms/toxicities among prostate cancer patients receiving RNT.

United statesLisa gudenkaufJournal of nuclear medicineMoffitt cancer centerHealthday newsFunctional assessmentCancer therapy radionuclideChronic illness therapy

vimarsana © 2020. All Rights Reserved.